Rapid identification by specific PCR of coagulase-negative staphylococcal species important in hospital infection

Journal of Medical Microbiology
S GribaldoJ Stanley

Abstract

Polymerase chain reaction (PCR) identification assays were designed for eight major species of coagulase-negative staphylococci (CNS) on the basis of three variable regions found in the 16S rRNA gene. The PCR assays were tested with 41 staphylococcal strains representing the diversity of staphylococci defined by classical biotyping schemes. Each PCR result was compared with species-specific polymorphism in and around the 16S rRNA gene (i.e., 16S ribotype) and the phenotypic identification of the strain in a miniaturised biochemical test gallery (bioMerieux ATB 32 Staph). Twenty-six of the 41 strains were identified by PCR as belonging to one of the eight species for which primers had been designed and none of the remaining strains was misidentified. For 22 of the 26 strains there was complete agreement between the PCR identification, 16S ribotype and ATB identification. For the remaining four strains there was agreement between PCR identification and 16S ribotype. Two National Collection of Type Culture strains were re-assigned to different species and 10 previously unassigned strains were formally speciated for the first time. These PCR assays are suitable for rapid and definitive speciation of CNS.

Citations

Oct 23, 2010·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M BergeronS Boisset
Apr 30, 1999·International Journal for Parasitology·R H Andrews, N B Chilton
Oct 10, 2008·The Journal of Antimicrobial Chemotherapy·Rosy ReynoldsUNKNOWN BSAC Working Parties on Resistance Surveillance
Aug 30, 2001·Journal of Clinical Microbiology·K J EdwardsN A Saunders
Aug 30, 2001·Journal of Clinical Microbiology·W J MasonM S Smeltzer
Feb 8, 2005·Journal of Clinical Microbiology·Srdjan StepanovicLuc A Devriese
Dec 15, 2015·BMC Microbiology·Hend ZeitounNourhan Fanaki
Aug 29, 1998·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·T MonsenJ Wiström
Nov 9, 2004·Folia Microbiologica·J StepánJ Doskar
May 12, 2001·The Breast Journal·Carol Fabian
Aug 20, 2002·The Journal of Veterinary Medical Science·Yoshihisa WakitaEiko Matsuo
Oct 26, 2002·The Journal of Veterinary Medical Science·Ryo YasudaShingo Hashikura
Jan 16, 2007·International Journal of Systematic and Evolutionary Microbiology·Mohammad Monir ShahTakayuki Ezaki

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.